Metraipolis › archive › dc_ac861fc2884e
Immunometabolic reprogramming in multiple sclerosis: from pathogenic amplifier to therapeutic target in neuroinflammation and remyelination — Europe PMC PMID:42518007
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42518007
- DOI
- 10.1007/s10787-[numero omesso]-y
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-17T14:13:43.724Z
- SHA-256 of the archived text
db371bb537153afb86e9142c3862fdbf6cdce72dd101ee6514368dd4b7c9e4dd- Stable URL of this page
https://metraipolis.com/documento/dc_ac861fc2884e
How to cite
Immunometabolic reprogramming in multiple sclerosis: from pathogenic amplifier to therapeutic target in neuroinflammation and remyelination — Europe PMC PMID:42518007 — Europe PMC (en), https://europepmc.org/article/MED/42518007 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ac861fc2884e (Metraipolis archive dc_ac861fc2884e, sha256 db371bb537153afb86e9142c3862fdbf6cdce72dd101ee6514368dd4b7c9e4dd)
BibTeX
@misc{dcac861fc2884e,
title = {Immunometabolic reprogramming in multiple sclerosis: from pathogenic amplifier to therapeutic target in neuroinflammation and remyelination — Europe PMC PMID:42518007},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42518007},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ac861fc2884e; sha256 db371bb537153afb86e9142c3862fdbf6cdce72dd101ee6514368dd4b7c9e4dd},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42518007. Agents can read the archived copy with the MCP tool read_document.